» Articles » PMID: 30499393

Structure, Functions and Selective Inhibitors of HDAC6

Overview
Specialty Chemistry
Date 2018 Dec 1
PMID 30499393
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Histone deacetylases 6 (HDAC6) has emerged as a promising target for the treatment of various human diseases including cancer, neurodegenerative disease and immunology due to its unique structure, substrate and biological functions. HDAC6 is involved in cell motility, cell survival, cell cycle progression, developmental events, prognosis as well as protein degradation and the involvement of HDAC6 in multiple biological processes has gained lots of attention. There is increasing interest in HDAC6 and its selective inhibitors. More than twenty years of synthetic efforts have developed various HDAC6 selective inhibitors with different Cap, linker and ZBG. This review will summarize recent research data regarding HDAC6 and various HDAC6 selective inhibitors.

Citing Articles

WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.

Oliveira-Silva J, Oliveira L, Chiminazo C, Fonseca R, Souza C, Aissa A Cancer Chemother Pharmacol. 2025; 95(1):22.

PMID: 39821335 DOI: 10.1007/s00280-024-04731-y.


The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?.

Spallotta F, Illi B Biomedicines. 2024; 12(11).

PMID: 39595195 PMC: 11591585. DOI: 10.3390/biomedicines12112631.


Effect of tubastatin A on NLRP3 inflammasome activation in macrophages under hypoxia/reoxygenation conditions.

Li H, Liu C, Cui Y, Chang P, Chong W World J Emerg Med. 2024; 15(4):289-296.

PMID: 39050221 PMC: 11265631. DOI: 10.5847/wjem.j.1920-8642.2024.059.


Male histone deacetylase 6 (HDAC6) knockout mice have enhanced ventilatory responses to hypoxic challenge.

Getsy P, Coffee G, Kelley T, Lewis S Front Physiol. 2024; 14:1332810.

PMID: 38384929 PMC: 10880035. DOI: 10.3389/fphys.2023.1332810.


HDAC6-selective inhibitor CAY10603 ameliorates cigarette smoke-induced small airway remodeling by regulating epithelial barrier dysfunction and reversing.

Zhang Q, Yan L, Lu Y, Liu X, Yin Y, Wang Q Respir Res. 2024; 25(1):66.

PMID: 38317159 PMC: 10840206. DOI: 10.1186/s12931-024-02688-3.